Skip to main content
TipRanks
Go Ultimate75% OFF

Avalo Therapeutics (AVTX) Balance Sheet

1,100 Followers

Avalo Therapeutics Balance Sheet

Avalo Therapeutics's total assets for Q3 2026 were $481.43M, a decrease of 1.91% from the previous quarter. AVTX total liabilities were $44.88M for the fiscal quarter, a 6.55% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 116.46M$ 150.73M$ 20.99M$ 33.37M$ 80.21M
$ 33.41M$ 17.70M$ 13.69M$ 44.28M$ 57.13M
$ 83.05M$ 133.03M$ 7.30M$ -10.91M$ 23.08M

Currency in USD

Avalo Therapeutics Liabilities to Assets

060M120M180M0 %50 %100 %150 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets